Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany

Blood (2022) 140 (4): 349–358.

https://doi.org/10.1182/blood.2021015209

Published: 2022

Includes: Supplemental data

Journal Articles

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Hardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher, Silke Frenz, Christina Verbruggen, Ana Yeguas, María Belén Vidriales, Marcos González, Judit Rial Saborido, Sabrina Kraus, Katrin Mestermann, Simone Thomas, Halvard Bonig, Maik Luu, Razieh Monjezi, Dimitrios Mougiakakos, Markus Sauer, Hermann Einsele, Michael Hudecek

Blood (2021) 138 (19): 1830–1842.

https://doi.org/10.1182/blood.2020009192

Published: 2021

Includes: Supplemental data

Journal Articles

Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis

Blood (2021) 138 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2021-151469

Published: 2021

Journal Articles

Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis

Blood (2021) 138 (Supplement 1): 3822.

https://doi.org/10.1182/blood-2021-146120

Published: 2021

Journal Articles

PRAME mRNA Expression in AML/MDS and HLA Genotype Analysis: Impact on Population Coverage and Design of TCR-Based Immunotherapies

Richard Addo, MD PhD, Kathrin Davari, PhD, Silke Raffegerst, PhD, Stefanie Tippmer, Dolores J. Schendel, PhD, Kai Pinkernell, MDMBA, Simone Thomas, MD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-140659

Published: 2020

Journal Articles

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

Daniel Heudobler, Sebastian Klobuch, MD, Florian Lüke, MD, Joachim Hahn, MD, Matthias Grube, MD, Stephan Kremers, MD, Thomas Südhoff, MD, Jörg Westermann, MD, Marie-Luise Huetter-Kroenke, MD, Peter Paschka, MD, Gauthier Bouche, Hartmut Döhner, MD, Wolfgang Herr, MD, Simone Thomas, MD, Albrecht Reichle, MD

Blood (2019) 134 (Supplement_1): 1382.

https://doi.org/10.1182/blood-2019-129977

Published: 2019

Journal Articles

CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

Hardikkumar Jetani, BPharm, MS, Irene García-Cadenas, Thomas Nerreter, Julian Rydzek, Simone Thomas, Wolfgang Herr, Jordi Sierra, Halvard Bönig, Hermann Einsele, Michael Hudecek

Blood (2017) 130 (Supplement 1): 1351.

https://doi.org/10.1182/blood.V130.Suppl_1.1351.1351

Published: 2017

Journal Articles

Adoptive Transfer of T-Cell-Receptor Engineered Human T Cells Specifically Reduces Viral Titers in HLA-Transgenic NSG Mice Infected with a Humanized Cytomegalovirus

Simone Thomas, MD, Niels Lemmermann, PhD, Sebastian Klobuch, MD, Jürgen Podlech, MD, Matthias Theobald, MD Prof., Matthias J Reddehase, PhD, Wolfgang Herr, MD PhD

Blood (2014) 124 (21): 3834.

https://doi.org/10.1182/blood.V124.21.3834.3834

Published: 2014

Journal Articles

Coexpression of the T-cell receptor constant α domain triggers tumor reactivity of single-chain TCR-transduced human T cells

Ralf-Holger Voss, Simone Thomas, Christina Pfirschke, Beate Hauptrock, Sebastian Klobuch, Jürgen Kuball, Margarete Grabowski, Renate Engel, Philippe Guillaume, Pedro Romero, Christoph Huber, Philipp Beckhove, Matthias Theobald

Blood (2010) 115 (25): 5154–5163.

https://doi.org/10.1182/blood-2009-11-254078

Published: 2010

Includes: Supplemental data

Journal Articles

Generation of CMV Specific T Cells From CMV Seronegative Donors by T Cell Receptor RNA Transfer.

Simone Thomas, Sebastian Klobuch, Mirjam H.M. Heemskerk, Diana Stolle, Katrin Besold, Bodo Plachter, Niels Schaft, Matthias Theobald, Ralf H Voss, Wolfgang Herr

Blood (2009) 114 (22): 3577.

https://doi.org/10.1182/blood.V114.22.3577.3577

Published: 2009

Journal Articles

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Eva Distler, Simone Thomas, Elke Schuerer, Cedrik Britten, Martin Schuler, Christoph Huber, Karin Kolbe, Thomas Woelfel, Ralf Meyer, Wolfgang Herr

Blood (2007) 110 (11): 4993.

https://doi.org/10.1182/blood.V110.11.4993.4993

Published: 2007

Journal Articles

Playing the Game Together: Coexpression of a Single Chain T Cell Receptor and a T Cell Receptor Constant-Alpha Domain Triggers Tumor Reactivity.

Simone Thomas, MD, Ralf H. Voss, PhD, Ratna Intan, Renate Engel, Juergen Kuball, MD, Christoph Huber, MD, Matthias Theobald, MD

Blood (2006) 108 (11): 3716.

https://doi.org/10.1182/blood.V108.11.3716.3716

Published: 2006

NARROW

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis

Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis

PRAME mRNA Expression in AML/MDS and HLA Genotype Analysis: Impact on Population Coverage and Design of TCR-Based Immunotherapies

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin

Adoptive Transfer of T-Cell-Receptor Engineered Human T Cells Specifically Reduces Viral Titers in HLA-Transgenic NSG Mice Infected with a Humanized Cytomegalovirus

Coexpression of the T-cell receptor constant α domain triggers tumor reactivity of single-chain TCR-transduced human T cells

Generation of CMV Specific T Cells From CMV Seronegative Donors by T Cell Receptor RNA Transfer.

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Playing the Game Together: Coexpression of a Single Chain T Cell Receptor and a T Cell Receptor Constant-Alpha Domain Triggers Tumor Reactivity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only